These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3594881)

  • 1. Immunoturbidimetry of apolipoprotein B in human serum.
    Irish GR; Barrantes DM; Ledue TB
    Clin Chem; 1987 Jul; 33(7):1267. PubMed ID: 3594881
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of apolipoproteins A-1 and B by immunoturbidimetry: detection of individuals at risk for atherosclerotic artery disease.
    Sullivan D; Kyne F; Maguire S; Sugrue D; Wright E; Garvey L; UaConaill D
    Ir J Med Sci; 1990 Mar; 159(3):65-7. PubMed ID: 2113894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum Apo A1 and Apo B: comparison of immunoturbidimetric and rate nephelometric techniques.
    Glueck CJ; McCray C; Speirs J
    Clin Chim Acta; 1991 Mar; 197(2):123-31. PubMed ID: 1904802
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoturbidimetry of apolipoprotein B in lyophilized human serum pools using primary standard.
    Sigalov AB; Alexandrovich OV
    Clin Chem; 1992 Jul; 38(7):1376. PubMed ID: 1623609
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardization of commercial assays for serum Apo A-I and Apo B: a consensus procedure for the calibration of reference materials.
    Dati F
    Scand J Clin Lab Invest Suppl; 1990; 198():73-9. PubMed ID: 2111938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial".
    van Tits LJ; de Graaf J; Stalenhoef AF
    Circulation; 2005 May; 111(18):e284-5; author reply e284-5. PubMed ID: 15883220
    [No Abstract]   [Full Text] [Related]  

  • 7. New assay of apolipoproteins A-I and B by rate nephelometry evaluated.
    Maciejko JJ; Levinson SS; Markyvech L; Smith MP; Blevins RD
    Clin Chem; 1987 Nov; 33(11):2065-9. PubMed ID: 3119254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.
    Brustolin D; Maierna M; Aguzzi F; Zoppi F; Tarenghi G; Berti G
    Clin Chem; 1991 May; 37(5):742-7. PubMed ID: 1903334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of 6 serum pools in standardization of the determination of apolipoproteins AI and B in the human serum].
    Beucler I; Caces E; Camare R; Dachet C; Fruchart JC; Gambert P; Girault A; Leglise D; Legrand A; Mainard F
    Ann Biol Clin (Paris); 1990; 48(7):443-7. PubMed ID: 2126170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of apolipoprotein B-containing lipoproteins for routine clinical laboratory use in cardiovascular disease.
    Levinson SS; Wagner SG
    Arch Pathol Lab Med; 1992 Dec; 116(12):1350-4. PubMed ID: 1456883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of apolipoprotein measurements.
    Cooper GR; Smith SJ; Henderson LO; Hannon WH
    Prog Clin Biol Res; 1988; 255():155-74. PubMed ID: 3124130
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for description of immunoassay kits.
    Aakvaag A; Leskinen E; Lindstedt G; Möller J; Nyberg A; Weber T
    Scand J Clin Lab Invest; 1990 Feb; 50(1):95-8. PubMed ID: 2315649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences.
    Noma A; Hata Y; Goto Y
    Clin Chim Acta; 1991 Jun; 199(2):147-57. PubMed ID: 1908362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia].
    Hachem H; Raynal G; Favre G; Hamza M; Canal P; Soula G
    Ann Biol Clin (Paris); 1985; 43(6):885-90. PubMed ID: 3938627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots.
    Bangert SK; Eldridge PH; Peters TJ
    Clin Chim Acta; 1992 Dec; 213(1-3):95-101. PubMed ID: 1477991
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactivity of a vancomycin degradation product in three immunoassays of vancomycin.
    Hortin GL; Landt M; Wilhite T; Smith CH
    Clin Chem; 1991 Nov; 37(11):2009. PubMed ID: 1934480
    [No Abstract]   [Full Text] [Related]  

  • 17. Discordant results in human chorionic gonadotropin assays.
    Cole LA; Kardana A
    Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misleading results with Opus Magnum hLH assay.
    Eskola-Williams A
    Clin Chem; 1997 Oct; 43(10):2008-10. PubMed ID: 9342035
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unreliable immunoassays, patients' safety, and clinical research.
    Lindstedt G; Frändberg S
    Lancet; 2002 Jan; 359(9303):356-7. PubMed ID: 11830234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.